Controlled release microspheres loaded with BMP7 suppress primary tumors from human glioblastoma

Ocoxin Modulates Cancer Stem Cells and M2 Macrophage Polarization in Glioblastoma

Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth

Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma.

NFATc3 controls tumour growth by regulating proliferation and migration of human astroglioma cells

Tumor-derived pericytes driven by EGFR mutations govern the vascular and immune microenvironment of gliomas.

Blood-Brain Barrier Disruption: A Common Driver of Central Nervous System Diseases.

Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype.